Examples of using Lymphomas in English and their translations into German
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Financial
-
Ecclesiastic
-
Political
-
Computer
-
Programming
-
Official/political
-
Political
Lymphomas, or cancers of the lymph nodes.
They belong to the extranodal lymphomas.
It is used for leukemias, lymphomas, breast cancer, lung cancer, head and neck cancers, and other cancers.
Approximately half the cases were lymphomas.
Follicular lymphomas are the most common, indolent non-Hodgkin lymphomas(NHL) in Western Europe and the United States.
This translocation is not found in every patient, and it is not specific for follicular lymphomas.
However, there are exceptions, among them prostate cancer, indolent lymphomas, brain tumours as well as neuroendocrine tumours.
This program, unlike any other, has been created specifically for follicular lymphoma and other indolent lymphomas.
This applies to the Hodgkin's lymphomas, the acute leukemias, the aggressive non-Hodgkin lymphomas, sarcomas, and certain brain tumors.
Cancers that have been successfully"cured" with chemotherapy include testicular cancers,certain leukemias, and lymphomas.
Tumors of the lymph nodes, called lymphomas, are malignant neoplasms that originate from the B cells or T cells of the lymphatic system.
Melanoma skin cancers is approximately 9.0 per 1000 patient years, and the observed rate of lymphomas is approximately 1.2 per 1000 patient years.
Lymphomas are cancers of the immune system affecting lymphocytes(a specific type of white blood cell) and cause enlargement of lymph nodes.
At present, the question whether there is a special risk formen with Klinefelter syndrome to acquire Non-Hodgkin lymphomas remains unanswered.
Grade 3B follicular lymphomas are considered as aggressive lymphomas and treated according to the recommendations for"Diffuse Large B Cell Lymphomas.
The observed rate of non- melanoma skin cancers is approximately 9.0 per 1000 patient years,and the observed rate of lymphomas is approximately 1.2 per 1000 patient years.
Science: Lymphomas According to researchers of the Karolinska Institute in Stockholm, Sweden, high CB1 and CB2 receptors levels are found in most non-Hodgkin lymphomas.
We have also been encouraged that several types of cancer are now largely well-controlled,including some lymphomas, low-risk prostate cancer and early-stage breast cancer.
However, ALK-negative lymphomas are known to respond to CHOP or similar chemotherapy regimens less favorably than their ALK-positive counterparts(5-year survival rates of 40-60%versus 70-90%) 36.
The standardized protocols enable high cure rates among patients with aggressive lymphomas and long, progression-free survival periods in patients with indolent lymphomas.
One focus is on the multimodal interdisciplinary treatment of lung cancer, on the treatment of breast cancer patients in cooperation with the breast center, onthe treatment of prostate cancer, of sarcomas, malignant lymphomas and pediatric tumors.
It is used to treat different types of cancer, such as lymphomas, leukemia, multiple myeloma, mycosis fungoides, neuroblastoma, ovarian cancer, retinoblastoma, breast cancer.
Other primary malignant tumours(mainly adenocarcinomas) are rare, they may involve the maxillary sinus or salivary glands;other examples are malignant lymphomas, Kaposi's sarcoma(particularly in AIDS), or metastases from other primary sites.
Further differential diagnoses are Neurofibromas, optic glioma, lymphomas, dermoid/epidermoids or an inflammatory pseudotumor. These lesions are usually able to be differentiated because of their localization, age characteristics and their imaging properties.
 In addition, Oct-2 expression is reported to be significantly greater in germinal center derived lymphomas, although other B cell lymphomas also display high levels of expression.
In concrete terms treatment options are being researched in brain tumours, leukaemia, lymphomas, infectious diseases such as hepatitis C and AIDS and in autoimmune disease such as rheumatoid arthritis and lupus.
It is used to treat various types of cancers, including sarcomas, some carcinomas(e.g., small cell lung cancer,squamous cell carcinoma of the head and neck and ovarian cancer), lymphomas, bladder cancer, cervical cancer, and germ cell tumors.
This covers drugs for various cancers(breast, colorectal, lung, ovarian, metastatic melanoma,pancreatic, lymphomas and leukemia) as well as modern medicines for inflammatory diseases, in the area of virology, transplantation and cardiology among others.
It can be diagnosed anddifferentiated from other forms of leukemia and lymphomas by the immunophenotype of the cells, cytochemistry and cytogenetic markers.
The very same OMS director, Michael Repacholi, found in 1997, a study of the Adelaida Hospital,Australia, lymphomas in transgenic mice exposed to 900 EMF of MHz, remembers in his Web the student Francisco Gabiola.